Intezyne raises $10M in series A

On Oct. 6, Intezyne Technologies Inc. (Tampa, Fla.) raised $10 million in an oversubscribed series A round led by existing investor Gaston Capital Healthcare Fund (GCHF). Undisclosed high-net-worth investors and family offices also participated.

CFO E. Russell McAllister told BioCentury that investors received preferred shares with an 8% paid-in-kind dividend, a liquidation preference and undisclosed benefits. He said the round's initial target was $8 million, and that the company expects the funds to last a year...